CD70 and renal cell carcinoma: For instance, CD70-directed CAR-engineered natural killer (CAR70-NK) cells derived from induced pluripotent stem cells (iPSCs) have demonstrated efficacy across various malignancies including RCC while also eliminating CD70-expressing alloreactive T cells.17